ACMG Education Workgroups
|
|
Credit Offered:
|
No Credit Offered
|
|
May 21 -Update on the Regulation of LDTs: FDA, VALID Act, CLIA Modernization
|
|
Overall Education Evaluation
|
|
2024 Education Program Needs Assessment
|
|
Education Committee Charter Revisions New August 2024 v5
|
|
Speed Dating Activity Proposal
|
|
Hereditary Cancer Testing: How Do We Scale Access, Improve Uptake and Equity?
|
|
Ryan Gates 44-48 Communication
|
|
Expiring Content Review Process
|
|
GGRC 2025 Faculty development
|
|
Continuing Certification Program Committee Charter Revisions Old-New October 2024 v3
|
|
2024 Digital Edition Evaluation Report
|
|
February 27 Evaluation Report
|
|
June 18 - Obtaining Funding from the Patient Centered Outcomes Research Institute (PCORI)
|
|
Education Committee Charter Revisions Old-New August 2024 v5
|
|
Achieving Health Equity in Genomic Medicine Research and Practice
|
|
Improving Patient Safety Test Questions FINAL
|
|
Seyma 40-44 QI and PT Safety
|
|
2 new questions - QI and PT Safety
|
|
2023 Live Meeting Evaluations
|
|
Meeting Minutes November 11
|
|
Continuing Certification Program Committee Revised Charter for Committee Review 111524
|
|
April 23 Evaluation Report
|
|
Early Genetics Trainee Forum - Fresh Perspectives on the Genetics Workforce Development & Diversity: A Panel of Current & Recent Trainees
|
|
Promise and Perils of Voluntary Workplace Genetic Testing
|
|
July 16 - Advances in Gene Therapy – 2024 Update
|
|
Safety Front Matter FINAL
|
|
Jinbo Fan - Error Redeuction slides 28-39
|
|
2023 Digital Edition Evaluation
|
|
CCP Committee Charter Review Meeting Minutes November 7
|
|
Early Career Genetic Mentor Luncheon
|
|
July 23 Evaluation Report
|
|
Transitions and Health Care of Adults with Genetic Syndromes
|
|
2021 Patient Safety Course Evaluation
|
|
2024 Revised questions (needs Q7-9)
|
|
September 17 - The Utility and Limitations of Diagnostic Transcriptome RNA
|
|
Continuing Certification Program Committee Charter for Review 121224
|
|
August 27 Evaluation Report
|
|
What's New in Neurotherapeutics? Review of Select Treatments Approved for Rare Neurological Disorders
|
|
Revised slides 1-78 (need 79-99)
|
|
October 15 - Classification Investigation
|
|
Dissecting Lateralized Overgrowth - Clinical and Molecular Diagnosis and Tumor Risk
|
|
September 24 Evaluation Report
|
|
November 19 - The Ethical Principles Every Geneticist Needs to Know
|
|
October 22 Evaluation Report
|